Integrated Filing- Governance

Valiant Laboratories Limited has submitted its Quarterly Integrated Filing (Governance) Report for the quarter ending December 31, 2024. The report confirms that the composition of the Board of Directors and its committees complies with SEBI regulations.

Notably, the company had no pending investor complaints at the start or end of the quarter, reflecting efficient grievance handling.

From an investor's standpoint, this compliance underscores strong corporate governance, which could enhance investor confidence and support a positive outlook for the company's stock.